|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Phase II Study with Symadex (C-1311) in Women with Metastatic Breast Cancer after Anthracycline and Taxane Failure
Start Date20 Feb 2006 |
Sponsor / Collaborator- |
Phase II Study with Symadex (C-1311) in Patients with Metastatic Colorectal Cancer after Oxaliplatin and/or Irinotecan Failure
Start Date25 Jan 2006 |
Sponsor / Collaborator- |
100 Clinical Results associated with TOP1 x FLT3 x Top II
100 Translational Medicine associated with TOP1 x FLT3 x Top II
0 Patents (Medical) associated with TOP1 x FLT3 x Top II